REHOVOT, Israel, Aug. 28, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology and chemistry company, today announced that Ofer Haviv, Evogene's President and CEO, will present at the H.C. Wainwright 27th Annual Global Investment Conference, 2025, taking place in New York, from September 8-10, 2025. SOURCE Evogene Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) is a pioneering AI-driven discovery and development company focused on creating novel small molecules for the pha ...

Conference call and webcast: today, August 19, 2025, 9:00 am ET Financial Highlights: REHOVOT, Israel, Aug. 19, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology and chemistry company aiming to revolutionize the development of life-science- based products, today announced its financial results for the second quarter ended June 30, 2025. Mr. Ofer Haviv, Evogene's President and CEO stated: "Evogene is entering a transformative phase, centered on the strategic repos ...